BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:54 PM | Browse: 121 | Download: 492
 |
Received |
|
2025-04-21 05:30 |
|
Peer-Review Started |
|
2025-04-21 05:30 |
|
First Decision by Editorial Office Director |
|
2025-04-28 09:03 |
|
Return for Revision |
|
2025-04-28 09:03 |
|
Revised |
|
2025-05-19 17:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-06-04 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-06-04 09:08 |
|
Articles in Press |
|
2025-06-04 09:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-02 00:35 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ju-Ping Xie, Ya-Jun Tang, You-Wen Fan, Ying-Zi Huang, Min Deng, Tian-Zhi Zhang, You Li, Gang Deng and Di Tang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Di Tang, Associate Chief Physician, Director, Department of General Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen 518107, Guangdong Province, China. tangdi@mail.sysu.edu.cn |
| Key Words |
Intrahepatic cholangiocarcinoma; Hepatic arterial infusion chemotherapy; Lenvatinib; Toripalimab; Surgery; Case report |
| Core Tip |
This report details an unresectable advanced intrahepatic cholangiocarcinoma (ICC) patient treated with first-line GEMOX-HAIC, lenvatinib, and toripalimab. This tri-modal therapy led to successful R0 resection and complete pathological remission. The patient achieved 29 months of disease-free survival. This rare case highlights a regimen enabling surgical resection and long-term survival in advanced ICC and discusses multidisciplinary management of severe biliary complications. However, as a single case, generalizability is limited. The regimen's efficacy and safety warrant validation in prospective, multi-center clinical trials. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
Xie JP, Tang YJ, Fan YW, Huang YZ, Deng M, Zhang TZ, Li Y, Deng G, Tang D. Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature. World J Gastrointest Oncol 2025; 17(7): 108650 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/108650.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.108650 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
